The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Global oncology authorship and access patterns.
 
Maria Teresa Bourlon
Honoraria - Tecnofarma; Tecnofarma
Consulting or Advisory Role - Asofarma; Bayer; Bristol-Myers Squibb; Eisai; Janssen Oncology; MSD Oncology; Novartis
Speakers' Bureau - Asofarma; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen Oncology; MSD Oncology
Expert Testimony - Asofarma
Travel, Accommodations, Expenses - Asofarma; Bristol-Myers Squibb (Mexico); Janssen-Cilag; MSD Oncology
 
Brenda Jimenez
No Relationships to Disclose
 
Charbel Fadi Matar
No Relationships to Disclose
 
Emilie M. Gunn
No Relationships to Disclose
 
Ophira M. Ginsburg
No Relationships to Disclose
 
Gilberto Lopes
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - AstraZeneca; Pfizer
Research Funding - Abbvie (Inst); adaptimmune (Inst); AstraZeneca; AstraZeneca (Inst); Bavarian Nordic (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); G1 Therapeutics (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); NOVARTIS (Inst); Pfizer (Inst); Rgenix (Inst); Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; E.R. Squibb Sons, LLC; Janssen; Pfizer
 
Eva Segelov
Consulting or Advisory Role - Athenex; Ipsen; MSD
Research Funding - Clinical Genomics (Inst)
Travel, Accommodations, Expenses - Amgen; Roche